Last reviewed · How we verify

NCT03824015: KAPA

Keeping Adults Physically Active Feasibility Study

Completed NA Last updated 31 January 2019
What this trial tests

NA trial testing Keeping Adults Physically Active (KAPA) intervention in Physical Activity in 50 participants. Completed in 22 April 2018.

Timeline
5 January 2017
Primary endpoint
22 April 2018
22 April 2018

Quick facts

Lead sponsorUniversity of Nottingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment50
Start date5 January 2017
Primary completion22 April 2018
Estimated completion22 April 2018

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

65 and older, any sex, with Physical Activity or Falls Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Keeping Adults Physically Active (KAPA) feasibility study aimed to examine the feasibility and acceptability of the an intervention designed to encourage the continuation of physical activity following the completion of a Falls Management Exercise program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A randomised feasibility study assessing an intervention to keep adults physically active after falls management exercise programmes end.
    Audsley S, Kendrick D, Logan P, Jones M, et al · · 2020 · cited 9× · PMID 32161660 · DOI 10.1186/s40814-020-00570-9

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03824015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing